David Steffin, MD

Trials

Studies that name David Steffin, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:03 UTC. Open this list on ClinicalTrials.gov

• Ph1
  NCT07513194 · GPC3 CAR T Cells With IL-15 and IL-21 for Recurrent ATRT and CNS Rhabdoid Tumors (RADIANT)

  Baylor College of Medicine · not yet recruiting · Atypical Teratoid Rhabdoid Tumor, Central Nervous System Rhabdoid Tumor · principal investigator
• Ph1
  NCT06198296 · Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells

  Baylor College of Medicine · recruiting · Hepatoblastoma, Hepatocellular Carcinoma, Wilms Tumor · principal investigator
• Ph1
  NCT04715191 · Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors

  Baylor College of Medicine · recruiting · Liver Cancer, Rhabdomyosarcoma, Malignant Rhabdoid Tumor · principal investigator
• Ph1
  NCT04377932 · Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors

  Baylor College of Medicine · active not recruiting · Liver Cancer, Rhabdomyosarcoma, Malignant Rhabdoid Tumor · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 11:03 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.